Track Nascent Biotech, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Nascent Biotech, Inc. NBIO · Stock Open Nascent Biotech, Inc. in new tab

0.000200 USD
Add to portfolio
P/B
-0.07
Beta
1.75
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Book Value0.00
Price to Book-0.07
% Insiders21.512%

DCF Valuation

Tweak assumptions to recompute fair value for Nascent Biotech, Inc. (NBIO)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Nascent Biotech, Inc. Logo Nascent Biotech, Inc. Analysis (NBIO)

United States Health Care Official Website Stock

Is Nascent Biotech, Inc. a good investment? Nascent Biotech, Inc. (NBIO) is currently trading at 0.000200 USD.

Investor FAQ

Does Nascent Biotech, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Nascent Biotech, Inc.?

Nascent Biotech, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. Nascent Biotech, Inc. is based in North Palm Beach, Florida.

Exchange Ticker
PNK (United States) NBIO
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion